USRE43617E1 - Tissue liquefaction and aspiration - Google Patents

Tissue liquefaction and aspiration Download PDF

Info

Publication number
USRE43617E1
USRE43617E1 US12/030,694 US3069408A USRE43617E US RE43617 E1 USRE43617 E1 US RE43617E1 US 3069408 A US3069408 A US 3069408A US RE43617 E USRE43617 E US RE43617E
Authority
US
United States
Prior art keywords
fluid
tissue
region
liquefied
temperature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related, expires
Application number
US12/030,694
Inventor
Mark S. Andrew
Mylina Andrew
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/384,655 external-priority patent/US5616120A/en
Priority claimed from US09/030,792 external-priority patent/US6544211B1/en
Priority claimed from US10/408,604 external-priority patent/US6676629B2/en
Priority to US12/030,694 priority Critical patent/USRE43617E1/en
Application filed by Individual filed Critical Individual
Publication of USRE43617E1 publication Critical patent/USRE43617E1/en
Application granted granted Critical
Assigned to CSC TRUST COMPANY OF DELAWARE reassignment CSC TRUST COMPANY OF DELAWARE SECURITY INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: ANDREW TECHNOLOGIES, LLC
Adjusted expiration legal-status Critical
Assigned to NOVOCURE LIMITED reassignment NOVOCURE LIMITED RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: BIOPHARMA CREDIT PLC
Assigned to NOVOCURE LIMITED reassignment NOVOCURE LIMITED RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Assignors: BIOPHARMA CREDIT PLC
Assigned to ANDREW TECHNOLOGIES, LLC reassignment ANDREW TECHNOLOGIES, LLC RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: CSC TRUST COMPANY OF DELAWARE
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61CDENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE
    • A61C17/00Devices for cleaning, polishing, rinsing or drying teeth, teeth cavities or prostheses; Saliva removers; Dental appliances for receiving spittle
    • A61C17/02Rinsing or air-blowing devices, e.g. using fluid jets or comprising liquid medication
    • A61C17/0208Rinsing or air-blowing devices, e.g. using fluid jets or comprising liquid medication combined with means providing suction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007Methods or devices for eye surgery
    • A61F9/00736Instruments for removal of intra-ocular material or intra-ocular injection, e.g. cataract instruments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/71Suction drainage systems
    • A61M1/77Suction-irrigation systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00017Electrical control of surgical instruments
    • A61B2017/00137Details of operation mode
    • A61B2017/00154Details of operation mode pulsed
    • A61B2017/00172Pulse trains, bursts, intermittent continuous operation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • A61B2018/00035Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open with return means
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B2018/044Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
    • A61B2018/046Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in liquid form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00Anatomical parts of the body
    • A61M2210/06Head
    • A61M2210/0612Eyes

Definitions

  • the present invention is directed toward a method for liquefying target tissue within a body and more particularly, toward a method of heating a biocompatible fluid and presenting such to target tissue, thereby liquefying the target tissue and aspirating it while leaving non-target tissue intact.
  • Prior thermal energy sources used in surgery have been “dry-heat” devices. Some examples are: thermal lasers, ultrasound, microwave, radio frequency, and electrosurgery devices. These dry-heat energy sources transfer heat from a surgical instrument to a tissue primarily by the heat transfer modalities of conduction and radiation. Thermal lasers, ultrasound, and microwave energy sources can liquefy tissue, but only at very high energy levels. If any of these dry-heat energy sources are placed in direct contact with target surgical tissue, there is no tissue differentiation. That is, healthy as well as unhealthy tissue will be liquefied. For example, collapsing cavitation bubbles in front of an ultrasound surgical instrument release a thermal energy of 13,000° F. per bubble.
  • U.S. Pat. No. 4,924,863 discloses a method for removing artherosclerotic plaque from a patient by heating the plaque under pressure for a limited period of time. When the plaque is heated, it liquefies without causing immediate death of the underlying tissue. The liquefied plaque is then aspirated from the body through a catheter.
  • the means used for heating the plaque is microwave or radio frequency energy. As discussed above, however, in an effort to control the level of energy being produced, all of the plaque may not liquefy.
  • U.S. Pat. No. 5,540,679 discloses the use of a balloon catheter for heating tissue in a patient's body.
  • a heating device is located within the balloon and is arranged for heating fluid inside the balloon.
  • unwanted tissue such as a tumor or an enlarged prostate gland
  • thermal conduction from the fluid through a wall of the balloon.
  • the heat destroys the tissue which is eventually absorbed into the patient's body.
  • This method uses conduction and as explained above, such a method creates such a high level of energy that there is no tissue differentiation. As a result, healthy tissue may be heated and ultimately destroyed.
  • U.S. Pat. No. 4,886,491 discloses a method of liposuction using an ultrasonic probe.
  • An ultrasonic probe tip is vibrated at a high frequency and a low amplitude. This method separates the fatty tissue and creates heat which melts some of the fatty tissue.
  • a saline irrigating solution is applied to the area which emulsifies the melted fatty tissue. The emulsified solution is then aspirated. Again, because of the high thermal energy input into the system there is no differentiation of tissue into target and non-target tissue.
  • the present invention is designed to overcome the deficiencies of the prior art discussed above. It is an object of this invention to provide a method for liquefying target tissue within a living body while leaving non-target tissue intact, and aspirating the liquefied tissue as it is liquefied.
  • a method for liquefying target tissue within a human body includes heating a biocompatible fluid, presenting this fluid to the target tissue which liquefies the tissue, while leaving non-target tissue intact, and aspirating the liquefied tissue as soon as it is liquefied.
  • the present invention discloses a novel energy source which allows for efficient, safe, minimally invasive, and cost-effective surgery for surgical procedures where the goal of the surgery is to remove unwanted tissue from the body, within a surgical tissue field.
  • the present invention also allows for the differentiation of target tissue from non-target tissue.
  • the surgical tissue field is defined as the actual anatomical landscape with which the surgeon is physically interacting.
  • Surgical tissue fields are comprised of multiple homogeneous tissue groups. Each of these homogeneous tissue groups has its own melting point. With the present invention, the melting point of a particular tissue group or unwanted tissue is determined in order to liquefy the tissue and rid the patient of the same.
  • FIGURE is an elevational view of a liquefaction and aspiration device of the present invention.
  • FIGURE a liquefaction and aspiration device constructed in accordance with the principles of the present invention and designated generally as 10 .
  • the liquefaction device 10 includes a hollow handpiece 12 with a first end 14 and a second end 16 .
  • An elongated cannula 18 extends from the first end 14 of the handpiece 12 and terminates in a tip 20 .
  • the tip 20 has three ports formed therethrough.
  • Three lumens 22 , 24 , and 26 are positioned in the cannula. Each of the lumens has one end communicating with a corresponding port and an opposite end extending into the handpiece 12 .
  • An irrigation tube 28 has one end thereof connected to the lumen 24 and an opposite end connected to a fluid source 30 .
  • the fluid source is heated by a heating element (not shown) that can be located within or outside of the handpiece 12 .
  • the heated fluid source 30 supplies heated fluid through the heated irrigation tube 28 and out of the tip 20 of the cannula 18 via the port associated with the lumen 24 .
  • a preferred heated fluid is a saline solution.
  • the saline solution is heated to a temperature between 98.6° F. and 250° F. This temperature defines the minimum threshold temperature of the liquid that is required to cause liquefaction of a specific substance when the heated liquid is presented to the specific substance.
  • the heated fluid can be fed utilizing a pump mechanism or simply by the force of gravity.
  • a cooled solution irrigation tube 32 has one end thereof connected to the lumen 26 and an opposite end connected to an irrigation supply source 34 .
  • the irrigation supply source supplies fluid through the irrigation tube 32 and out of the tip 20 of the cannula via the port associated with the lumen 26 .
  • the preferred irrigation solution is a saline solution.
  • the irrigation supply source is preferably mounted above the handpiece 12 so that gravity continuously feeds the irrigation solution through the irrigation tube 32 and out of the tip 20 of the cannula 18 . It should be readily apparent, however, that a pump could also be used.
  • This irrigation solution may be chilled pre-operatively or cooled intra-operatively.
  • the preferred temperature for the cooled solution is believed to be approximately 40° F., although the optimal temperature will vary depending on the temperature of the heated solution and the configuration of the tip 20 . That is, the temperatures of the solutions will vary depending on the type of tissue being liquefied. Furthermore, the tip 20 is disposable and may vary in size and shape depending upon what area of the body is being treated.
  • An aspiration tube 36 has one end connected to the lumen 22 and the opposite end connected to a vacuum source 37 .
  • the vacuum source 37 causes the target tissue and the saline solution to be aspirated from the surgical tissue field through the tip 20 of the cannula via the port associated with the lumen 24 . It should be noted that all of the above operations are preferably controlled through a controller circuit 38 .
  • a cooled solution is fed through the irrigation tube 32 , through the lumen 26 and out the corresponding port in the tip 20 of the cannula 18 .
  • the flow from the irrigation source 34 is controlled by the surgeon in a manner well known in the art (e.g., a foot actuated flow control switch).
  • the tip 20 of the cannula 18 is inserted into the surgical tissue field. Heated saline solution is fed through the tube 28 , through the lumen 24 , and out of the tip 20 .
  • the solution should be heated to the melting point of the target tissue.
  • the target tissue Upon contact with the heated solution, the target tissue rapidly liquefies.
  • the natural melting point of the target tissue may be taken advantage of to achieve selective liquefaction. It is because the total thermal energy input into the system is so low and because the thermal energy is liquid and in motion that selective liquefaction is achieved.
  • most target surgical tissue has a lower melting point than non-target tissue because the non-target (or non-pathologic) tissue has greater structural integrity than target (or pathologic tissue).
  • the liquefied tissue and solution are aspirated through the lumen 22 and through the aspirating tube 36 when the vacuum source 37 is activated in a manner well known in the art, such as through the use of a foot pedal.
  • the aspiration and irrigation take place simultaneously.
  • the aspiration takes place substantially throughout the procedure. That is, it is believed that it is neither necessary nor desirable to liquefy the entire target tissue before aspirating the same. Rather, as a portion of the target tissue is liquefied by the heated solution, it is irrigated by the cooled solution and aspirated. This process continues until the entire target tissue has been liquefied and aspirated. In some systems, however, irrigation is not necessary and the liquefied tissue may be aspirated without irrigation.
  • the present method applies an energy source to the target tissue in order to liquefy the same.
  • the present method differs from prior art methods in that the energy source in the present method is “wet-heat.” That is, it uses the heat transfer modality of convection primarily rather than the heat transfer modalities of conduction and radiation.
  • the present method uses a surgical device, such as a catheter or a handpiece as described above, through which solution is ejected under a minimal degree of pressure.
  • the solution has to be “in motion” because the target tissue is liquefied by the heat transfer principle of convection. In this manner the target tissue, which may be fatty tissue, is liquefied and aspirated.
  • liquefaction also refers to “gelifaction” or “gelifying.” That is, the “liquid” may be part liquid, part gel, or part vapor, as long as that liquid is of such a state of matter that can be aspirated with low pressure suction/aspiration technology.
  • a “solid,” on the other hand, is a state of matter that cannot be aspirated with the present low pressure suction/aspiration technology.
  • aspiration refers to the technology of low pressure suction/aspiration, such as the procedure used in irrigation/aspiration procedures in cataract extraction. However, this does not eliminate the possibility of using higher pressure aspiration systems in some selected surgical sites.
  • the present method may also be used in such areas as prostatectomy, vascular atherectomy/thrombectomy, and tumor removal.
  • the target tissue may be subcutaneous fat, atheromatous plaque, or a uterine fibroid.
  • the tip may be any size and shape in order to accommodate the area of the body being treated.
  • the tip, cannula, and tubes may be replaced in order to re-use the device.
  • Chemically active facilitators may be added to the liquid that is to be heated in order to achieve additional efficaciousness of liquefaction.
  • fibrinolysin and EDTA may be used to liquify a fibrin-rich, calcium-rich atheromatous plaque.
  • a cytotoxic chemical agent may be added to the liquid in order to remove a tumor.
  • the apparatus of the present invention may also be used for dental procedures.
  • the cannula is connected to a source of heated fluid where the fluid may be a continuous flow or pulsed so that heated fluid is repeatedly expressed from the tip of the cannula.
  • the cannula is directed through an opening formed in dental enamel.
  • the heated fluid is directed at diseased dentin tissue lying under the hole in the dental enamel.
  • the fluid may be saline, disinfectant, an antibiotic, abrasive solutions, or the like.
  • other chemicals may be added to the fluid.
  • the diseased tissue of the tooth is liquefied and aspirated as discussed above. Additional application of heated fluid may be delivered to kill any residual bacteria or other microorganisms and then aspirated.
  • the hole may be filled with dental filler material typically used in such a procedure. Additional dental uses may include root canal surgery, plaque removal, calculus removal, soft tissue surgery, and teeth whitening.
  • the bolus size per pulse was 0.27 ml.
  • Room temperature tap water was poured into the water pik well. The temperature was measured at 80° F.
  • the tip of the water pik was placed directly on the first fat cube and the water pik was turned on.
  • the pulsating water was exposed to the fat cube for approximately one minute. There was no discernible effect.
  • the same procedure was carried out on the second fat cube. Again, there was no discernible effect.
  • the two fat cubes in the experimental group were then subjected to the same procedure as the control group with the exception that the water pik well was now filled with 120° F. tap water. Again, the water pik was turned on with the tip in the same place and was allowed to run for about one minute. In the first cube there was a tremendous effect. A 95% reduction in the mass of the cube was observed. There was no obvious effect on either the muscle tissue or on the blood vessel. There was a whitish fat liquid left in the tray. This liquid fat did not re-solidify and it readily poured out of the tray. The second fat cube was subjected to the same procedure, with the same result.
  • the invention can also be used for “cellular stripping.” This is accomplished by utilizing the moving heated bicompatible fluid to “strip” off cells that are clinging to a wall.
  • the invention would include the concept of the stripping of bacterial cells that are clinging to a wall of dental tissue, for example. This would allow for the complete removal of any residual bacterial cells that would be lingering around after the diseased tissue was liquefied and aspirated.
  • the stripped cells are not subjected to liquefaction as described above. Rather, they are simply stripped from their attachment to a wall, and then aspirated from the site by aspirating the resultant liquid “slurry” comprised of saline, or other liquid, and bacterial cells dispersed within this liquid medium.

Abstract

A method and apparatus are disclosed for liquefying target tissue within a body and aspirating the same while leaving non-target tissue intact. A biocompatible fluid is heated and contacted with target tissue so that the target tissue is melted while non-target tissue remains intact. As the target tissue is being melted it is also aspirated from the body.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a continuation-in-part of U.S. patent application Ser. No. 10/408,604, filed Apr. 7, 2003, now U.S. Pat. No. 6,676,629 which is a continuation-in-part of U.S. patent application Ser. No. 09/030,792, filed Feb. 26, 1998, now U.S. Pat. No. 6,544,211, which is a continuation-in-part of U.S. application Ser. No. 08/823,713, filed Mar. 25, 1997, now U.S. Pat. No. 6,074,358, which is a division of U.S. application Ser. No. 08/384,655, filed Feb. 6, 1995, now U.S. Pat. No. 5,616,120.
BACKGROUND OF THE INVENTION
The present invention is directed toward a method for liquefying target tissue within a body and more particularly, toward a method of heating a biocompatible fluid and presenting such to target tissue, thereby liquefying the target tissue and aspirating it while leaving non-target tissue intact.
Prior thermal energy sources used in surgery have been “dry-heat” devices. Some examples are: thermal lasers, ultrasound, microwave, radio frequency, and electrosurgery devices. These dry-heat energy sources transfer heat from a surgical instrument to a tissue primarily by the heat transfer modalities of conduction and radiation. Thermal lasers, ultrasound, and microwave energy sources can liquefy tissue, but only at very high energy levels. If any of these dry-heat energy sources are placed in direct contact with target surgical tissue, there is no tissue differentiation. That is, healthy as well as unhealthy tissue will be liquefied. For example, collapsing cavitation bubbles in front of an ultrasound surgical instrument release a thermal energy of 13,000° F. per bubble. With such a high thermal energy input there is no differentiation of tissue within the surgical tissue field. That is, all tissue target and non-target, within the target field melts or liquefies. The thermal energy in thermal lasers and ultrasound is inherently high, so the heat cannot be “turned down” or reduced. In microwave, radio frequency, and electrosurgery the level of thermal energy may be reduced but in so doing, liquefaction of tissue is not achieved at all. Rather, cauterization or coagulation of the tissue results.
U.S. Pat. No. 4,924,863 discloses a method for removing artherosclerotic plaque from a patient by heating the plaque under pressure for a limited period of time. When the plaque is heated, it liquefies without causing immediate death of the underlying tissue. The liquefied plaque is then aspirated from the body through a catheter. The means used for heating the plaque is microwave or radio frequency energy. As discussed above, however, in an effort to control the level of energy being produced, all of the plaque may not liquefy.
U.S. Pat. No. 5,540,679 discloses the use of a balloon catheter for heating tissue in a patient's body. A heating device is located within the balloon and is arranged for heating fluid inside the balloon. When the fluid is heated, unwanted tissue, such as a tumor or an enlarged prostate gland, is heated by thermal conduction from the fluid through a wall of the balloon. The heat destroys the tissue which is eventually absorbed into the patient's body. This method uses conduction and as explained above, such a method creates such a high level of energy that there is no tissue differentiation. As a result, healthy tissue may be heated and ultimately destroyed.
U.S. Pat. No. 4,886,491 discloses a method of liposuction using an ultrasonic probe. An ultrasonic probe tip is vibrated at a high frequency and a low amplitude. This method separates the fatty tissue and creates heat which melts some of the fatty tissue. A saline irrigating solution is applied to the area which emulsifies the melted fatty tissue. The emulsified solution is then aspirated. Again, because of the high thermal energy input into the system there is no differentiation of tissue into target and non-target tissue.
SUMMARY OF THE INVENTION
The present invention is designed to overcome the deficiencies of the prior art discussed above. It is an object of this invention to provide a method for liquefying target tissue within a living body while leaving non-target tissue intact, and aspirating the liquefied tissue as it is liquefied.
It is another object of the invention to provide a method for liquefying target tissue by heating a biocompatible fluid and presenting the same to the target tissue.
It is a further object of the invention to provide a method for liquefying fatty tissue and aspirating the same from a patient.
In accordance with the illustrative embodiments, demonstrating features and advantages of the present invention, there is provided a method for liquefying target tissue within a human body. The method includes heating a biocompatible fluid, presenting this fluid to the target tissue which liquefies the tissue, while leaving non-target tissue intact, and aspirating the liquefied tissue as soon as it is liquefied.
The present invention discloses a novel energy source which allows for efficient, safe, minimally invasive, and cost-effective surgery for surgical procedures where the goal of the surgery is to remove unwanted tissue from the body, within a surgical tissue field. The present invention also allows for the differentiation of target tissue from non-target tissue. In other words, the surgical tissue field is defined as the actual anatomical landscape with which the surgeon is physically interacting. Surgical tissue fields are comprised of multiple homogeneous tissue groups. Each of these homogeneous tissue groups has its own melting point. With the present invention, the melting point of a particular tissue group or unwanted tissue is determined in order to liquefy the tissue and rid the patient of the same.
Other objects, features, and advantages of the invention will be readily apparent from the following detailed description of a preferred embodiment thereof taken in conjunction with the drawings.
BRIEF DESCRIPTION OF THE DRAWING
For the purpose of illustrating the invention, there is shown in the accompanying drawing one form which is presently preferred; it being understood that the invention is not intended to be limited to the precise arrangements and instrumentalities shown.
The sole FIGURE is an elevational view of a liquefaction and aspiration device of the present invention.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
Referring now to the drawing in detail, there is shown in the FIGURE a liquefaction and aspiration device constructed in accordance with the principles of the present invention and designated generally as 10.
The liquefaction device 10 includes a hollow handpiece 12 with a first end 14 and a second end 16. An elongated cannula 18 extends from the first end 14 of the handpiece 12 and terminates in a tip 20. The tip 20 has three ports formed therethrough. Three lumens 22, 24, and 26 are positioned in the cannula. Each of the lumens has one end communicating with a corresponding port and an opposite end extending into the handpiece 12.
An irrigation tube 28 has one end thereof connected to the lumen 24 and an opposite end connected to a fluid source 30. The fluid source is heated by a heating element (not shown) that can be located within or outside of the handpiece 12. The heated fluid source 30 supplies heated fluid through the heated irrigation tube 28 and out of the tip 20 of the cannula 18 via the port associated with the lumen 24. A variety of solutions that are compatible with the tissue being treated can be utilized. However, a preferred heated fluid is a saline solution. The saline solution is heated to a temperature between 98.6° F. and 250° F. This temperature defines the minimum threshold temperature of the liquid that is required to cause liquefaction of a specific substance when the heated liquid is presented to the specific substance. The heated fluid can be fed utilizing a pump mechanism or simply by the force of gravity.
A cooled solution irrigation tube 32 has one end thereof connected to the lumen 26 and an opposite end connected to an irrigation supply source 34. The irrigation supply source supplies fluid through the irrigation tube 32 and out of the tip 20 of the cannula via the port associated with the lumen 26. Once again, the preferred irrigation solution is a saline solution. The irrigation supply source is preferably mounted above the handpiece 12 so that gravity continuously feeds the irrigation solution through the irrigation tube 32 and out of the tip 20 of the cannula 18. It should be readily apparent, however, that a pump could also be used. This irrigation solution may be chilled pre-operatively or cooled intra-operatively. The preferred temperature for the cooled solution is believed to be approximately 40° F., although the optimal temperature will vary depending on the temperature of the heated solution and the configuration of the tip 20. That is, the temperatures of the solutions will vary depending on the type of tissue being liquefied. Furthermore, the tip 20 is disposable and may vary in size and shape depending upon what area of the body is being treated.
An aspiration tube 36 has one end connected to the lumen 22 and the opposite end connected to a vacuum source 37. The vacuum source 37 causes the target tissue and the saline solution to be aspirated from the surgical tissue field through the tip 20 of the cannula via the port associated with the lumen 24. It should be noted that all of the above operations are preferably controlled through a controller circuit 38.
A cooled solution is fed through the irrigation tube 32, through the lumen 26 and out the corresponding port in the tip 20 of the cannula 18. The flow from the irrigation source 34 is controlled by the surgeon in a manner well known in the art (e.g., a foot actuated flow control switch).
To carry out the present method, the tip 20 of the cannula 18 is inserted into the surgical tissue field. Heated saline solution is fed through the tube 28, through the lumen 24, and out of the tip 20. The solution should be heated to the melting point of the target tissue. Upon contact with the heated solution, the target tissue rapidly liquefies. By manipulating the temperature of the biocompatible liquid, the natural melting point of the target tissue may be taken advantage of to achieve selective liquefaction. It is because the total thermal energy input into the system is so low and because the thermal energy is liquid and in motion that selective liquefaction is achieved. Generally, most target surgical tissue has a lower melting point than non-target tissue because the non-target (or non-pathologic) tissue has greater structural integrity than target (or pathologic tissue).
The liquefied tissue and solution are aspirated through the lumen 22 and through the aspirating tube 36 when the vacuum source 37 is activated in a manner well known in the art, such as through the use of a foot pedal. The aspiration and irrigation take place simultaneously. Furthermore, it should be noted that the aspiration takes place substantially throughout the procedure. That is, it is believed that it is neither necessary nor desirable to liquefy the entire target tissue before aspirating the same. Rather, as a portion of the target tissue is liquefied by the heated solution, it is irrigated by the cooled solution and aspirated. This process continues until the entire target tissue has been liquefied and aspirated. In some systems, however, irrigation is not necessary and the liquefied tissue may be aspirated without irrigation.
The present method applies an energy source to the target tissue in order to liquefy the same. The present method differs from prior art methods in that the energy source in the present method is “wet-heat.” That is, it uses the heat transfer modality of convection primarily rather than the heat transfer modalities of conduction and radiation.
In liquefaction, temperature is more influential than pressure; however, the heated solution must be “in motion” for liquefaction to occur. The present method uses a surgical device, such as a catheter or a handpiece as described above, through which solution is ejected under a minimal degree of pressure. The solution has to be “in motion” because the target tissue is liquefied by the heat transfer principle of convection. In this manner the target tissue, which may be fatty tissue, is liquefied and aspirated.
It should be noted that the concept of liquefaction also refers to “gelifaction” or “gelifying.” That is, the “liquid” may be part liquid, part gel, or part vapor, as long as that liquid is of such a state of matter that can be aspirated with low pressure suction/aspiration technology. A “solid,” on the other hand, is a state of matter that cannot be aspirated with the present low pressure suction/aspiration technology. Furthermore, aspiration refers to the technology of low pressure suction/aspiration, such as the procedure used in irrigation/aspiration procedures in cataract extraction. However, this does not eliminate the possibility of using higher pressure aspiration systems in some selected surgical sites.
The present method may also be used in such areas as prostatectomy, vascular atherectomy/thrombectomy, and tumor removal. Furthermore, the target tissue may be subcutaneous fat, atheromatous plaque, or a uterine fibroid. Again, the tip may be any size and shape in order to accommodate the area of the body being treated. Also, the tip, cannula, and tubes may be replaced in order to re-use the device. Chemically active facilitators may be added to the liquid that is to be heated in order to achieve additional efficaciousness of liquefaction. For example, fibrinolysin and EDTA may be used to liquify a fibrin-rich, calcium-rich atheromatous plaque. Also, a cytotoxic chemical agent may be added to the liquid in order to remove a tumor.
The apparatus of the present invention may also be used for dental procedures. As described above, the cannula is connected to a source of heated fluid where the fluid may be a continuous flow or pulsed so that heated fluid is repeatedly expressed from the tip of the cannula. For treatment of dental caries, the cannula is directed through an opening formed in dental enamel. The heated fluid is directed at diseased dentin tissue lying under the hole in the dental enamel. The fluid may be saline, disinfectant, an antibiotic, abrasive solutions, or the like. Furthermore, other chemicals may be added to the fluid. The diseased tissue of the tooth is liquefied and aspirated as discussed above. Additional application of heated fluid may be delivered to kill any residual bacteria or other microorganisms and then aspirated. Only decayed or diseased tissue and bacteria would be removed while leaving the viable hard or soft tissue, such as the healthy dental tissue, including nerve tissue, and blood vessels intact. Afterward, the hole may be filled with dental filler material typically used in such a procedure. Additional dental uses may include root canal surgery, plaque removal, calculus removal, soft tissue surgery, and teeth whitening.
EXAMPLE
Four pieces of tissue were cut from fresh bovine subcutaneous fat surrounded by muscle tissue and blood vessels. Each piece was approximately two inches by two inches by two inches. Each cube of tissue contained about 95% fat tissue and 5% muscle tissue with some obvious blood vessels present. Two cubes were placed in a control group and two cubes were placed in an experimental group. The control group cubes were taken from the refrigerator and placed in a microwave oven for two five-second intervals at a high temperature setting. This was done in order to raise the temperature of the fat tissue to approximately human body temperature. The two cubes were placed in a tray. A water pik (Teledyne Water Pik, model WP-20W) was set at a pressure setting of 5 which equates to 75 psi. The liquid shoots out at 20 pulses per second. The bolus size per pulse was 0.27 ml. Room temperature tap water was poured into the water pik well. The temperature was measured at 80° F. The tip of the water pik was placed directly on the first fat cube and the water pik was turned on. The pulsating water was exposed to the fat cube for approximately one minute. There was no discernible effect. The same procedure was carried out on the second fat cube. Again, there was no discernible effect.
The two fat cubes in the experimental group were then subjected to the same procedure as the control group with the exception that the water pik well was now filled with 120° F. tap water. Again, the water pik was turned on with the tip in the same place and was allowed to run for about one minute. In the first cube there was a tremendous effect. A 95% reduction in the mass of the cube was observed. There was no obvious effect on either the muscle tissue or on the blood vessel. There was a whitish fat liquid left in the tray. This liquid fat did not re-solidify and it readily poured out of the tray. The second fat cube was subjected to the same procedure, with the same result.
While the invention has been described in connection with the concept of liquefacation, it is not limited thereto. The invention can also be used for “cellular stripping.” This is accomplished by utilizing the moving heated bicompatible fluid to “strip” off cells that are clinging to a wall. In dental applications it would include the concept of the stripping of bacterial cells that are clinging to a wall of dental tissue, for example. This would allow for the complete removal of any residual bacterial cells that would be lingering around after the diseased tissue was liquefied and aspirated. The stripped cells are not subjected to liquefaction as described above. Rather, they are simply stripped from their attachment to a wall, and then aspirated from the site by aspirating the resultant liquid “slurry” comprised of saline, or other liquid, and bacterial cells dispersed within this liquid medium.
The present invention may be embodied in other specific forms without departing from the spirit or essential attributes thereof and accordingly, reference should be made to the appended claims rather than to the foregoing specification as indicating the scope of the invention.

Claims (28)

1. A method for liquefying diseased dentin tissue within a body comprising the steps of:
heating a biocompatible fluid;
presenting said fluid to the diseased tissue within a surgical area so that the tissue is liquefied when contacted with said heated fluid while leaving healthy tissue intact; and
aspirating said liquefied tissue.
2. The method as claimed in claim 1 wherein said fluid is saline.
3. The method as claimed in claim 1 wherein the dentin tissue is the diseased tissue lying underneath a hole formed in the enamel of a tooth.
4. The method as claimed in claim 1 wherein said heating step includes heating said fluid to a temperature at which temperature only the diseased tissue liquefies.
5. The method as claimed in claim 1 wherein said fluid is heated to a temperature between 98.6 and 250° F.
6. The method as claimed in claim 1 further including the step of adding chemical substances to the heated fluid to facilitate liquefying the diseased tissue.
7. The method as claimed in claim 1 further including the step of irrigating the surgical area while simultaneously aspirating said liquefied tissue.
8. The method of claim 1 further including the steps of irrigating the surgical area as a portion of the diseased tissue is liquefied and aspirated and repeating said presenting, irrigating, and aspirating steps until the desired amount of said diseased tissue has been liquefied and aspirated.
9. A method of removing fat tissue from a region within a body that contains both fat tissue and other tissue, the method comprising the steps of:
presenting moving fluid to the tissues in the region, wherein the pressure and temperature of the fluid are such that (a) fat tissue in the region is liquefied by the fluid and (b) the other tissue in the region remains intact; and
aspirating the liquefied fat tissue and the fluid.
10. The method of claim 9, wherein the fluid comprises saline.
11. The method of claim 9, wherein the temperature of the fluid is about 120° F.
12. A method of removing fat tissue from a region within a body that contains both fat tissue and other tissue, the method comprising the steps of:
presenting numerous pulses of fluid to the tissues in the region, wherein the pressure and temperature of the pulses of fluid are such that (a) fat tissue in the region is liquefied by the pulses of fluid and (b) the other tissue in the region remains intact; and
aspirating the liquefied fat tissue and the fluid.
13. The method of claim 12, wherein, in the presenting step, a plurality of pulses are delivered per second.
14. The method of claim 12, wherein, in the presenting step, the pulses are delivered at a rate of about 20 pulses per second.
15. The method of claim 12, wherein, in the presenting step, each pulse contains about ¼ ml of fluid.
16. The method of claim 12, wherein, in the presenting step, the pulses are delivered at a pressure of about 75 psi.
17. The method of claim 12, wherein the fluid comprises saline.
18. The method of claim 12, wherein the temperature of the fluid is about 120° F.
19. The method of claim 18, wherein, in the presenting step, a plurality of pulses are delivered per second.
20. An apparatus for removing subcutaneous fat tissue from a region within a body that contains both fat tissue and other tissue, the apparatus comprising:
a heating element configured to heat a fluid;
a conduit configured to direct the fluid to the tissues in the region;
a pump adapted to pump the fluid through the conduit so that the fluid impinges on the tissues in the region, at a pressure and temperature that causes (a) the fat tissue in the region to be liquefied by the impinging fluid and (b) the other tissue in the region to remain intact; and
an aspiration tube operatively connected to a vacuum source for aspirating the liquefied fat and the fluid from the region.
21. The apparatus of claim 20, wherein the heated fluid is obtained by heating water contained in a reservoir to a set temperature.
22. The apparatus of claim 20, wherein the pump pumps the fluid by ejecting a plurality of boluses of fluid per second.
23. The apparatus of claim 22, wherein about 20 boluses are ejected per second.
24. The apparatus of claim 22, wherein each bolus contains about ¼ ml of fluid.
25. The apparatus of claim 20, wherein the fluid is delivered to the tissues in the region at a pressure of about 75 psi.
26. The apparatus of claim 20, wherein the fluid comprises saline.
27. The apparatus of claim 20, wherein the fluid is delivered to the tissues in the region at a temperature of about 120° F.
28. The apparatus of claim 27, wherein the pump pumps the fluid by ejecting a plurality of boluses of fluid per second.
US12/030,694 1995-02-06 2008-02-13 Tissue liquefaction and aspiration Expired - Fee Related USRE43617E1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US12/030,694 USRE43617E1 (en) 1995-02-06 2008-02-13 Tissue liquefaction and aspiration

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US08/384,655 US5616120A (en) 1995-02-06 1995-02-06 Method and apparatus for lenticular liquefaction and aspiration
US08/823,713 US6074358A (en) 1995-02-06 1997-03-25 Method and apparatus for lenticular liquefaction and aspiration
US09/030,792 US6544211B1 (en) 1995-02-06 1998-02-26 Tissue liquefaction and aspiration
US10/408,604 US6676629B2 (en) 1995-02-06 2003-04-07 Tissue liquefaction and aspiration for dental treatment
US10/752,798 US7011644B1 (en) 1995-02-06 2004-01-07 Tissue liquefaction and aspiration for dental treatment
US12/030,694 USRE43617E1 (en) 1995-02-06 2008-02-13 Tissue liquefaction and aspiration

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US10/752,798 Reissue US7011644B1 (en) 1995-02-06 2004-01-07 Tissue liquefaction and aspiration for dental treatment

Publications (1)

Publication Number Publication Date
USRE43617E1 true USRE43617E1 (en) 2012-08-28

Family

ID=35998717

Family Applications (2)

Application Number Title Priority Date Filing Date
US10/752,798 Ceased US7011644B1 (en) 1995-02-06 2004-01-07 Tissue liquefaction and aspiration for dental treatment
US12/030,694 Expired - Fee Related USRE43617E1 (en) 1995-02-06 2008-02-13 Tissue liquefaction and aspiration

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US10/752,798 Ceased US7011644B1 (en) 1995-02-06 2004-01-07 Tissue liquefaction and aspiration for dental treatment

Country Status (1)

Country Link
US (2) US7011644B1 (en)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US7992725B2 (en) * 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
WO2003099412A1 (en) * 2002-05-24 2003-12-04 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US20060058823A1 (en) * 2004-09-14 2006-03-16 Dimalanta Ramon C Handpiece pumping chamber
WO2006086199A1 (en) * 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
WO2006086201A2 (en) 2005-02-07 2006-08-17 Hanuman Llc Platelet rich plasma concentrate apparatus and method
US20060264896A1 (en) * 2005-05-09 2006-11-23 Palmer Erika I Minimally invasive apparatus and method for treatment of a tumor associated with a bone
AU2007240780B2 (en) 2006-04-20 2014-01-16 Sonendo, Inc. Apparatus and methods for treating root canals of teeth
US10835355B2 (en) 2006-04-20 2020-11-17 Sonendo, Inc. Apparatus and methods for treating root canals of teeth
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20080014545A1 (en) * 2006-05-31 2008-01-17 Doug Schippers Apical irrigation fluid delivery apparatus
US7980854B2 (en) 2006-08-24 2011-07-19 Medical Dental Advanced Technologies Group, L.L.C. Dental and medical treatments and procedures
WO2008047490A1 (en) * 2006-10-17 2008-04-24 Osaka University Dental apparatus
EP2821027A3 (en) * 2007-01-25 2015-04-01 Sonendo, Inc. Apparatus for removing organic material from a root canal of a tooth
JP5479319B2 (en) 2007-04-12 2014-04-23 バイオメット・バイオロジックス・リミテッド・ライアビリティ・カンパニー Buoy suspension fractionation system
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
WO2008134713A1 (en) * 2007-04-30 2008-11-06 Andrew Technologies Llc Liposuction based on tissue liquefaction
US8366700B2 (en) * 2007-04-30 2013-02-05 Andrew Technologies, Llc Liposuction of visceral fat using tissue liquefaction
US20130261606A1 (en) * 2007-04-30 2013-10-03 Andrew Technologies Llc Harvesting Fat Tissue Using Tissue Liquefaction
EP2620139B1 (en) 2008-02-27 2016-07-20 Biomet Biologics, LLC Interleukin-1 receptor antagonist rich solutions
US8337711B2 (en) 2008-02-29 2012-12-25 Biomet Biologics, Llc System and process for separating a material
US8012077B2 (en) * 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
KR101306537B1 (en) 2008-06-04 2013-09-09 콜게이트-파아므올리브캄파니 Oral care implement with cavitation system
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
WO2011011619A1 (en) * 2009-07-23 2011-01-27 Andrew Technologies Llc Apparatus for removing pulp from a tooth
EP3878398B1 (en) 2009-11-13 2024-03-06 Sonendo, Inc. Dental treatment apparatus
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
BR112013009708A2 (en) 2010-10-21 2016-07-19 Sonendo Inc endodontic treatment apparatus, methods and compositions
EP2701617A2 (en) * 2011-04-29 2014-03-05 Andrew Technologies LLC Harvesting fat tissue using tissue liquefaction
CN110623765A (en) 2012-03-22 2019-12-31 索南多股份有限公司 Apparatus and method for cleaning teeth
US10631962B2 (en) 2012-04-13 2020-04-28 Sonendo, Inc. Apparatus and methods for cleaning teeth and gingival pockets
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US10363120B2 (en) 2012-12-20 2019-07-30 Sonendo, Inc. Apparatus and methods for cleaning teeth and root canals
EP3572036B1 (en) 2012-12-20 2021-05-26 Sonendo, Inc. Apparatus for cleaning teeth and root canals
EP2951019B1 (en) 2013-02-04 2018-12-19 Sonendo, Inc. Dental treatment system
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
EP2991576B1 (en) 2013-05-01 2022-12-28 Sonendo, Inc. Apparatus and system for treating teeth
CA2911415A1 (en) 2013-06-26 2014-12-31 Sonendo, Inc. Apparatus and methods for filling teeth and root canals
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US10172688B2 (en) * 2015-06-24 2019-01-08 Carlos Andres Castro-Perdomo Steam cleaning device and methods of use
US10806544B2 (en) 2016-04-04 2020-10-20 Sonendo, Inc. Systems and methods for removing foreign objects from root canals
CN110338924B (en) * 2019-06-05 2021-08-06 中南大学湘雅医院 Oral care device
USD997355S1 (en) 2020-10-07 2023-08-29 Sonendo, Inc. Dental treatment instrument

Citations (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247851A (en) 1962-03-13 1966-04-26 Seibert Margaretta Jean Apparatus for applying liquids to the body
US3351063A (en) 1964-12-08 1967-11-07 Stephen F Malaker Cryosurgical probe
US3589363A (en) 1967-07-25 1971-06-29 Cavitron Corp Material removal apparatus and method employing high frequency vibrations
US3624907A (en) 1968-06-06 1971-12-07 Michele Brass Devices for the rational washing of tooth root canals with simultaneous suction of the outflowing liquid and related improved devices
US3693613A (en) 1970-12-09 1972-09-26 Cavitron Corp Surgical handpiece and flow control system for use therewith
US3906954A (en) 1973-09-14 1975-09-23 Nasa Ophthalmic liquifaction pump
US3930505A (en) * 1974-06-24 1976-01-06 Hydro Pulse Corporation Surgical apparatus for removal of tissue
US4019514A (en) 1974-06-03 1977-04-26 Surgical Design Corporation Surgical system for controlling the infusion of fluid to and the evacuation of fluid and material from an operating field
US4078564A (en) 1976-02-24 1978-03-14 Novo Enzyme Corporation Intralenticular cataract surgery
US4191176A (en) 1976-02-24 1980-03-04 Novo Laboratories, Inc. Intralenticular cataract surgery
US4215476A (en) 1977-03-25 1980-08-05 Armstrong Alexander S Health services combination irrigator and aspirator
US4386927A (en) 1979-10-12 1983-06-07 Ocular Associates Device to be utilized in extracapsular cataract surgery
US4411652A (en) 1981-08-21 1983-10-25 The Regents Of The University Of California Internally sterile pulsatile infusor system
US4496342A (en) 1981-03-20 1985-01-29 Surgical Design Corporation Surge prevention system for an ophthalmic instrument
US4597388A (en) 1983-12-15 1986-07-01 Trutek Research, Inc. Apparatus for removing cataracts
US4650461A (en) 1985-06-10 1987-03-17 Woods Randall L Extracapasular cortex irrigation and extraction
US4694828A (en) 1986-04-21 1987-09-22 Eichenbaum Daniel M Laser system for intraocular tissue removal
US4744360A (en) 1986-12-18 1988-05-17 Bath Patricia E Apparatus for ablating and removing cataract lenses
US4764165A (en) 1986-07-17 1988-08-16 Mentor O & O, Inc. Ophthalmic aspirator-irrigator with valve
US4784649A (en) * 1987-03-20 1988-11-15 The Cooper Companies, Inc. Surgical aspirator cannula
US4804364A (en) 1985-07-19 1989-02-14 Satelec Apparatus for the curettage or exeresis of biological tissues by means of an instrument vibrating at ultrasound frequencies
US4817599A (en) 1987-12-30 1989-04-04 Drews Robert C To and fro washing system and method
US4857063A (en) * 1988-01-19 1989-08-15 Usa Medical Surgical aspirator
US4869715A (en) 1988-04-21 1989-09-26 Sherburne Fred S Ultrasonic cone and method of construction
US4883426A (en) * 1987-12-03 1989-11-28 Ferrer Euler R Dental implement for fluid aspiration and tissue retraction
US4886491A (en) 1988-02-29 1989-12-12 Tulio Parisi Liposuction procedure with ultrasonic probe
US4924863A (en) 1988-05-04 1990-05-15 Mmtc, Inc. Angioplastic method for removing plaque from a vas
WO1990005493A1 (en) 1988-11-15 1990-05-31 Svedman Paal Surgical instrument
US4950267A (en) 1987-11-27 1990-08-21 Olympus Optical Co., Ltd. Laser beam treatment device for an endoscope
US4995880A (en) 1989-09-26 1991-02-26 Galib Samuel H Intraocular lens and method of surgically implanting same in an eye
US5022413A (en) 1988-04-21 1991-06-11 Spina Jr Joseph Intralenticular cataract surgical procedure
US5061255A (en) 1985-10-15 1991-10-29 Albert Greenfeld Exterior antimigration refinements for self-cleaning indwelling therapeutic articles
EP0485133A1 (en) 1990-11-08 1992-05-13 Possis Medical, Inc. Asymmetric water jet atherectomy
US5169396A (en) 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5222953A (en) 1991-10-02 1993-06-29 Kambiz Dowlatshahi Apparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated
US5257988A (en) 1991-07-19 1993-11-02 L'esperance Medical Technologies, Inc. Apparatus for phacoemulsifying cataractous-lens tissue within a protected environment
US5324319A (en) 1990-09-05 1994-06-28 Breg, Inc. Gravity driven therapeutic fluid circulation device
US5451208A (en) 1991-05-03 1995-09-19 Goldrath; Milton H. Endometrium coagulating apparatus and surgical method for thermal destruction of the endometrium
US5540679A (en) 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US5607420A (en) 1992-02-25 1997-03-04 Surgical Laser Technologies, Inc. Surgical tool for use with a contact laser
US5649923A (en) 1988-10-24 1997-07-22 The General Hospital Corporation Catheter devices for delivering laser energy
US5653692A (en) 1995-09-07 1997-08-05 Innerdyne Medical, Inc. Method and system for direct heating of fluid solution in a hollow body organ
US6074358A (en) 1995-02-06 2000-06-13 Andrew; Mark S. Method and apparatus for lenticular liquefaction and aspiration
US6224378B1 (en) 1997-07-09 2001-05-01 Surgijet, Inc. Method and apparatus for dental treatment using high pressure liquid jet
WO2001076518A1 (en) 2000-04-07 2001-10-18 Surgijet, Inc. Method and apparatus for thermal emulsification
US6440103B1 (en) 1999-03-17 2002-08-27 Surgijet, Inc. Method and apparatus for thermal emulsification
US20020188280A1 (en) 2001-06-06 2002-12-12 Hien Nguyen Fat removal device and method
US6497572B2 (en) 1997-07-09 2002-12-24 Surgijet, Inc. Apparatus for dental treatment using high pressure liquid jet
US6544211B1 (en) * 1995-02-06 2003-04-08 Mark S. Andrew Tissue liquefaction and aspiration
US20030120199A1 (en) 1998-06-04 2003-06-26 Glenn Sussman Method of operating a liquefracture handpiece
US6676629B2 (en) 1995-02-06 2004-01-13 Mark S. Andrew Tissue liquefaction and aspiration for dental treatment
WO2004037095A2 (en) 2002-10-25 2004-05-06 Hydrocision, Inc. Surgical devices incorporating liquid jet assisted tissue maniputation and methods for their use
US20060100606A1 (en) 2004-11-10 2006-05-11 Dobak John D Iii Method and device for liposuction
US20060224154A1 (en) 2001-12-07 2006-10-05 Shadduck John H Medical instrument and method of use
WO2007087404A2 (en) 2006-01-24 2007-08-02 Hydrocision, Inc. Liquid jet surgical instrument having a distal end with a selectively controllable shape
WO2008134713A1 (en) 2007-04-30 2008-11-06 Andrew Technologies Llc Liposuction based on tissue liquefaction

Patent Citations (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3247851A (en) 1962-03-13 1966-04-26 Seibert Margaretta Jean Apparatus for applying liquids to the body
US3351063A (en) 1964-12-08 1967-11-07 Stephen F Malaker Cryosurgical probe
US3589363A (en) 1967-07-25 1971-06-29 Cavitron Corp Material removal apparatus and method employing high frequency vibrations
US3624907A (en) 1968-06-06 1971-12-07 Michele Brass Devices for the rational washing of tooth root canals with simultaneous suction of the outflowing liquid and related improved devices
US3693613A (en) 1970-12-09 1972-09-26 Cavitron Corp Surgical handpiece and flow control system for use therewith
US3906954A (en) 1973-09-14 1975-09-23 Nasa Ophthalmic liquifaction pump
US4019514A (en) 1974-06-03 1977-04-26 Surgical Design Corporation Surgical system for controlling the infusion of fluid to and the evacuation of fluid and material from an operating field
US3930505A (en) * 1974-06-24 1976-01-06 Hydro Pulse Corporation Surgical apparatus for removal of tissue
US4078564A (en) 1976-02-24 1978-03-14 Novo Enzyme Corporation Intralenticular cataract surgery
US4135516A (en) 1976-02-24 1979-01-23 Novo Laboratories, Incorporated Delivery apparatus and method for treatment of intralenticular cataracts with exogenous enzymes
US4191176A (en) 1976-02-24 1980-03-04 Novo Laboratories, Inc. Intralenticular cataract surgery
US4078564B1 (en) 1976-02-24 1986-09-16
US4215476A (en) 1977-03-25 1980-08-05 Armstrong Alexander S Health services combination irrigator and aspirator
US4386927A (en) 1979-10-12 1983-06-07 Ocular Associates Device to be utilized in extracapsular cataract surgery
US4496342A (en) 1981-03-20 1985-01-29 Surgical Design Corporation Surge prevention system for an ophthalmic instrument
US4411652A (en) 1981-08-21 1983-10-25 The Regents Of The University Of California Internally sterile pulsatile infusor system
US4597388A (en) 1983-12-15 1986-07-01 Trutek Research, Inc. Apparatus for removing cataracts
US4650461A (en) 1985-06-10 1987-03-17 Woods Randall L Extracapasular cortex irrigation and extraction
US4804364A (en) 1985-07-19 1989-02-14 Satelec Apparatus for the curettage or exeresis of biological tissues by means of an instrument vibrating at ultrasound frequencies
US5061255A (en) 1985-10-15 1991-10-29 Albert Greenfeld Exterior antimigration refinements for self-cleaning indwelling therapeutic articles
US4694828A (en) 1986-04-21 1987-09-22 Eichenbaum Daniel M Laser system for intraocular tissue removal
US4764165A (en) 1986-07-17 1988-08-16 Mentor O & O, Inc. Ophthalmic aspirator-irrigator with valve
US4744360A (en) 1986-12-18 1988-05-17 Bath Patricia E Apparatus for ablating and removing cataract lenses
US4784649A (en) * 1987-03-20 1988-11-15 The Cooper Companies, Inc. Surgical aspirator cannula
US4950267A (en) 1987-11-27 1990-08-21 Olympus Optical Co., Ltd. Laser beam treatment device for an endoscope
US4883426A (en) * 1987-12-03 1989-11-28 Ferrer Euler R Dental implement for fluid aspiration and tissue retraction
US4817599A (en) 1987-12-30 1989-04-04 Drews Robert C To and fro washing system and method
US4857063A (en) * 1988-01-19 1989-08-15 Usa Medical Surgical aspirator
US4886491A (en) 1988-02-29 1989-12-12 Tulio Parisi Liposuction procedure with ultrasonic probe
US4869715A (en) 1988-04-21 1989-09-26 Sherburne Fred S Ultrasonic cone and method of construction
US5022413A (en) 1988-04-21 1991-06-11 Spina Jr Joseph Intralenticular cataract surgical procedure
US4924863A (en) 1988-05-04 1990-05-15 Mmtc, Inc. Angioplastic method for removing plaque from a vas
US5649923A (en) 1988-10-24 1997-07-22 The General Hospital Corporation Catheter devices for delivering laser energy
WO1990005493A1 (en) 1988-11-15 1990-05-31 Svedman Paal Surgical instrument
US4995880A (en) 1989-09-26 1991-02-26 Galib Samuel H Intraocular lens and method of surgically implanting same in an eye
US5169396A (en) 1990-06-08 1992-12-08 Kambiz Dowlatshahi Method for interstitial laser therapy
US5324319A (en) 1990-09-05 1994-06-28 Breg, Inc. Gravity driven therapeutic fluid circulation device
EP0485133A1 (en) 1990-11-08 1992-05-13 Possis Medical, Inc. Asymmetric water jet atherectomy
US5451208A (en) 1991-05-03 1995-09-19 Goldrath; Milton H. Endometrium coagulating apparatus and surgical method for thermal destruction of the endometrium
US5257988A (en) 1991-07-19 1993-11-02 L'esperance Medical Technologies, Inc. Apparatus for phacoemulsifying cataractous-lens tissue within a protected environment
US5222953A (en) 1991-10-02 1993-06-29 Kambiz Dowlatshahi Apparatus for interstitial laser therapy having an improved temperature sensor for tissue being treated
US5607420A (en) 1992-02-25 1997-03-04 Surgical Laser Technologies, Inc. Surgical tool for use with a contact laser
US5540679A (en) 1992-10-05 1996-07-30 Boston Scientific Corporation Device and method for heating tissue in a patient's body
US6074358A (en) 1995-02-06 2000-06-13 Andrew; Mark S. Method and apparatus for lenticular liquefaction and aspiration
US6676629B2 (en) 1995-02-06 2004-01-13 Mark S. Andrew Tissue liquefaction and aspiration for dental treatment
US6544211B1 (en) * 1995-02-06 2003-04-08 Mark S. Andrew Tissue liquefaction and aspiration
US6319222B1 (en) 1995-02-06 2001-11-20 Mark S. Andrew Method and apparatus for lenticular liquefaction and aspiration
US5653692A (en) 1995-09-07 1997-08-05 Innerdyne Medical, Inc. Method and system for direct heating of fluid solution in a hollow body organ
US6497572B2 (en) 1997-07-09 2002-12-24 Surgijet, Inc. Apparatus for dental treatment using high pressure liquid jet
US6224378B1 (en) 1997-07-09 2001-05-01 Surgijet, Inc. Method and apparatus for dental treatment using high pressure liquid jet
US20030120199A1 (en) 1998-06-04 2003-06-26 Glenn Sussman Method of operating a liquefracture handpiece
US6440103B1 (en) 1999-03-17 2002-08-27 Surgijet, Inc. Method and apparatus for thermal emulsification
WO2001076518A1 (en) 2000-04-07 2001-10-18 Surgijet, Inc. Method and apparatus for thermal emulsification
US20020188280A1 (en) 2001-06-06 2002-12-12 Hien Nguyen Fat removal device and method
US20060224154A1 (en) 2001-12-07 2006-10-05 Shadduck John H Medical instrument and method of use
WO2004037095A2 (en) 2002-10-25 2004-05-06 Hydrocision, Inc. Surgical devices incorporating liquid jet assisted tissue maniputation and methods for their use
US20060100606A1 (en) 2004-11-10 2006-05-11 Dobak John D Iii Method and device for liposuction
WO2007087404A2 (en) 2006-01-24 2007-08-02 Hydrocision, Inc. Liquid jet surgical instrument having a distal end with a selectively controllable shape
WO2008134713A1 (en) 2007-04-30 2008-11-06 Andrew Technologies Llc Liposuction based on tissue liquefaction

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Litigation Search for USPN 7011644, Jun. 23, 2011. *
Product Information for the Human med Body-Jet, Jul. 2004.
Product Information for the Smith & Nephew Versajet Hydrosurgery, 2004.

Also Published As

Publication number Publication date
US7011644B1 (en) 2006-03-14

Similar Documents

Publication Publication Date Title
USRE43617E1 (en) Tissue liquefaction and aspiration
US6676629B2 (en) Tissue liquefaction and aspiration for dental treatment
US6544211B1 (en) Tissue liquefaction and aspiration
US4985027A (en) Soft tissue aspiration device and method
US5102410A (en) Soft tissue cutting aspiration device and method
US5419761A (en) Liposuction apparatus and associated method
JP2709358B2 (en) Treatment device for patients with blood vessels blocked by deposits
US4692139A (en) Catheter for effecting removal of obstructions from a biological duct
EP1370321B1 (en) Ultrasonic catheter drug delivery device
JPS6136255Y2 (en)
US7184827B1 (en) Shrinkage of dilatations in the body
JP4890674B2 (en) Sheath used for ultrasonic elements
JPH05168645A (en) Ultrasonic dissection separator for atherosclerosis spot
US7056315B2 (en) Liposuction apparatus with pressurized liquid spray and liposuction method using the apparatus
JPS6363450A (en) Water jet operation apparatus
JP2003510159A (en) Ultrasound therapy method and ultrasound therapy device for reducing prostate in particular
BRPI0720286A2 (en) LASER POWER DEVICE FOR SOFT TISSUE REMOVAL
US20110098564A1 (en) Method and apparatus for diagnosing and treating vascular disease
US7931029B2 (en) Method and apparatus for uterus stabilization
KR100936407B1 (en) Piezo insert for operating an implant surgical operation using piezoelectric device
RU2214193C2 (en) Method, system and instrument for ultrasonic action on blood vessel or cavernous body
JP2011511670A (en) Liposuction of visceral fat using tissue liquefaction
Wuchinich Ultrasonic surgical aspiration: instrumentation, clinical experience, and safety
CN201948988U (en) Ureteroscope fluid filling device
Blanc et al. Surgical hysteroscopy: equipment and technique

Legal Events

Date Code Title Description
FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: CSC TRUST COMPANY OF DELAWARE, DELAWARE

Free format text: SECURITY INTEREST;ASSIGNOR:ANDREW TECHNOLOGIES, LLC;REEL/FRAME:033875/0299

Effective date: 20140930

FEPP Fee payment procedure

Free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.)

LAPS Lapse for failure to pay maintenance fees

Free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.)

AS Assignment

Owner name: NOVOCURE LIMITED, JERSEY

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:BIOPHARMA CREDIT PLC;REEL/FRAME:052383/0705

Effective date: 20190424

AS Assignment

Owner name: NOVOCURE LIMITED, JERSEY

Free format text: RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825;ASSIGNOR:BIOPHARMA CREDIT PLC;REEL/FRAME:052391/0549

Effective date: 20190424

AS Assignment

Owner name: ANDREW TECHNOLOGIES, LLC, DELAWARE

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:CSC TRUST COMPANY OF DELAWARE;REEL/FRAME:054778/0846

Effective date: 20201229